Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
JCO Clinical Cancer Informatics
|
March 28, 2020
Building a Clinically Relevant Risk Model: Predicting Risk of a Potentially Preventable Acute Care Visit for Patients Starting Antineoplastic Treatment
Bobby Daly, Dmitriy Gorenshteyn, Kevin J Nicholas, et al.
JAMA Network Open
|
March 4, 2022
Analysis of a Remote Monitoring Program for Symptoms Among Adults With Cancer Receiving Antineoplastic Therapy
Bobby Daly, Kevin Nicholas, Jessica Flynn, et al.
Journal of Oncology Practice
|
July 18, 2018
Misery Loves Company: Presenting Symptom Clusters to Urgent Care by Patients Receiving Antineoplastic Therapy
Bobby Daly, Kevin Nicholas, Dmitriy Gorenshteyn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 26, 2018
Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations
Zishuo I Hu, Jinru Shia, Zsofia K Stadler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 25, 2020
Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline <i>BRCA/PALB2</i> Mutation
Eileen M O'Reilly, Jonathan W Lee, Mark Zalupski, et al.
Journal of the National Cancer Institute
|
June 13, 2025
Clinical utility and tissue concordance of circulating tumor DNA in pancreatic ductal adenocarcinoma
Fergus Keane, Lily V Saadat, Catherine A O'Connor, et al.
JAMA Network Open
|
February 2, 2023
Clinical Importance of Clonal Hematopoiesis in Metastatic Gastrointestinal Tract Cancers
Bill H Diplas, Ryan Ptashkin, Joanne F Chou, et al.
Cancer
|
August 5, 2021
Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes
Parisa Momtaz, Catherine A O'Connor, Joanne F Chou, et al.
The Lancet. Oncology
|
May 22, 2020
First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial
Yelena Y Janjigian, Steven B Maron, Walid K Chatila, et al.
JCO Oncology Practice
|
May 30, 2020
InSight Care Pilot Program: Redefining Seeing a Patient
Bobby Daly, Gilad Kuperman, Alice Zervoudakis, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
JCO Clinical Cancer Informatics
|
March 28, 2020
Building a Clinically Relevant Risk Model: Predicting Risk of a Potentially Preventable Acute Care Visit for Patients Starting Antineoplastic Treatment
Bobby Daly, Dmitriy Gorenshteyn, Kevin J Nicholas, et al.
JAMA Network Open
|
March 4, 2022
Analysis of a Remote Monitoring Program for Symptoms Among Adults With Cancer Receiving Antineoplastic Therapy
Bobby Daly, Kevin Nicholas, Jessica Flynn, et al.
Journal of Oncology Practice
|
July 18, 2018
Misery Loves Company: Presenting Symptom Clusters to Urgent Care by Patients Receiving Antineoplastic Therapy
Bobby Daly, Kevin Nicholas, Dmitriy Gorenshteyn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 26, 2018
Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations
Zishuo I Hu, Jinru Shia, Zsofia K Stadler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 25, 2020
Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline <i>BRCA/PALB2</i> Mutation
Eileen M O'Reilly, Jonathan W Lee, Mark Zalupski, et al.
Journal of the National Cancer Institute
|
June 13, 2025
Clinical utility and tissue concordance of circulating tumor DNA in pancreatic ductal adenocarcinoma
Fergus Keane, Lily V Saadat, Catherine A O'Connor, et al.
JAMA Network Open
|
February 2, 2023
Clinical Importance of Clonal Hematopoiesis in Metastatic Gastrointestinal Tract Cancers
Bill H Diplas, Ryan Ptashkin, Joanne F Chou, et al.
Cancer
|
August 5, 2021
Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes
Parisa Momtaz, Catherine A O'Connor, Joanne F Chou, et al.
The Lancet. Oncology
|
May 22, 2020
First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial
Yelena Y Janjigian, Steven B Maron, Walid K Chatila, et al.
JCO Oncology Practice
|
May 30, 2020
InSight Care Pilot Program: Redefining Seeing a Patient
Bobby Daly, Gilad Kuperman, Alice Zervoudakis, et al.
Page
of 3